|
14:00
|
Major examples: UPGx Trial, Clinic and drug development
Matthias Schwab (Tübingen/DE) Talk time: 25 min |
|
||
|
14:25
|
Diagnostic platforms (Illumina, Agena, Sequencing, Maldi…)
Matthias Schwab (Tübingen/DE), Volker Lauschke (Stockholm/SE) Talk time: 25 min |
|
||
|
14:50
|
Scientific progress, drug development, population pharmacogenomics (rare variants, NGS, AI prediction tools, functional modeling)
Volker Lauschke (Stockholm/SE) Talk time: 25 min |
|
||
|
15:15
|
Coffee break
Talk time: 15 min |
|
||
|
15:30
|
Evidence evaluation, Role of regulatory authorities
Julia Stingl (Aachen/DE) Talk time: 15 min |
|
||
|
15:45
|
Guidelines: Rote Hand, CPIC, Drug Label, GendiagnostikRL, IVDR
Julia Stingl (Aachen/DE) Talk time: 15 min |
|
||
|
16:00
|
Clinical Decision Support
Matthias Schwab (Tübingen/DE), Julia Stingl (Aachen/DE) Talk time: 15 min |
|
||
|
16:15
|
Current Implementation in Healthcare Systems (UPGx, Ausland: NL, DE)
Matthias Schwab (Tübingen/DE) Talk time: 15 min |
|
||
|
16:30
|
Discussion
Talk time: 30 min |
|
||